Key result
Amlodipine significantly reduced LDL cholesterol compared to valsartan in patients with newly diagnosed essential hypertension.
Why the study?
Does amlodipine reduce LDL compared to valsartan in patients with newly diagnosed essential hypertension?
Observational
Does amlodipine reduce LDL compared to valsartan in patients with newly diagnosed essential hypertension?
Answers are grounded in this paper and cite their sources.
Amlodipine may offer additional LDL-lowering benefits compared to valsartan in patients with newly diagnosed essential hypertension, suggesting baseline lipid profiles could help guide antihypertensive drug choice.
Hypertension is a modifiable risk factor for cardiovascular diseases and is associated with several metabolic disorders like dyslipidemia. Higher levels of triglyceride and low-density lipoprotein (LDL) are quite strong factors for the development of cardiovascular diseases. In this study, we investigated the effects of valsartan and amlodipine on the lipid profile in patients with newly diagnosed essential hypertension. We observed a beneficial effect of amlodipine on the lipid profile with a significant reduction of LDL compared to valsartan. In the treatment of hypertension, prior knowledge of the plasma cholesterol levels can be important in antihypertensive drug choice.
No takes yet. Share an insight, caveat, or question.
Arslan et al. (2012) conducted an observational in newly diagnosed essential hypertension. Amlodipine vs. Valsartan was evaluated on lipid profile (LDL reduction). Amlodipine significantly reduced LDL cholesterol compared to valsartan in patients with newly diagnosed essential hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: